PICTON MAHONEY ASSET MANAGEMENT - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 24 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PICTON MAHONEY ASSET MANAGEMENT ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q2 2022$9,000
-52.6%
91,6650.0%0.00%
-100.0%
Q1 2022$19,000
-26.9%
91,665
+120.0%
0.00%0.0%
Q4 2021$26,000
+4.0%
41,6660.0%0.00%0.0%
Q3 2021$25,000
-35.9%
41,6660.0%0.00%0.0%
Q2 2021$39,00041,6660.00%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 66,666$651,0000.02%
DIFESA CAPITAL MANAGEMENT, LP 14,159$3,0000.00%
MARSHALL WACE, LLP 108,584$1,065,0000.00%
Arena Capital Advisors, LLC- CA 69,251$14,0000.00%
Dryden Capital, LLC 15,000$3,0000.00%
PICTON MAHONEY ASSET MANAGEMENT 91,665$19,0000.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 100,000$20,0000.00%
PERISCOPE CAPITAL INC. 154,800$31,0000.00%
MMCAP International Inc. SPC 73,525$15,0000.00%
GABELLI & Co INVESTMENT ADVISERS, INC. 21,896$4,0000.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders